Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isobaric ropivacaine is a long-acting amide local anesthetic used for regional and local anesthesia. It's a specific formulation of ropivacaine that has the same density as cerebrospinal fluid, making it particularly useful for spinal anesthesia. ## Pharmacology and Mechanism of Action Isobaric ropivacaine works by reversibly inhibiting sodium ion influx in nerve fibers, blocking the propagation of action potentials[2]. As an amide local anesthetic, it preferentially binds and inactivates sodium channels in the open state. What makes ropivacaine unique is that it's manufactured as a pure S(-) enantiomer, which has significantly less cardiotoxicity and neurotoxicity compared to other local anesthetics like bupivacaine[2][5]. Ropivacaine is less lipophilic than other local anesthetics such as bupivacaine, making it less likely to penetrate large myelinated motor fibers. This property allows it to selectively act on the nociceptive A, B, and C fibers over the AB (motor) fibers, resulting in a differential sensory-motor blockade[2]. ## Clinical Applications Isobaric ropivacaine is primarily used for: - Spinal anesthesia for lower abdominal surgeries - Epidural anesthesia and analgesia - Regional nerve blocks - Surgical anesthesia including cesarean sections Studies have shown that isobaric ropivacaine provides a faster recovery from sensory block and achieves a higher segmental height (T10 and T8) compared to isobaric bupivacaine[6]. It also demonstrates fewer side effects such as bradycardia and hypotension[6]. ## Dosage and Administration For spinal anesthesia in lower limb orthopedic surgeries, studies have calculated: - ED50 (effective dose in 50% of patients): 15mg - ED95 (effective dose in 95% of patients): 20mg[8] In clinical trials, isobaric ropivacaine has been used at various concentrations: - 0.75% (22.5mg in 3mL) for intrathecal administration in lower abdominal surgeries[6] - 0.5% for epidural blocks in cesarean sections[2] ## Advantages Over Other Local Anesthetics Compared to bupivacaine, isobaric ropivacaine offers: 1. Faster recovery from sensory block 2. Higher segmental height achievement 3. Lower rates of side effects and complications 4. Higher threshold for cardiotoxicity and CNS toxicity 5. Shorter duration of motor block (0.9 hrs vs. 2.5 hrs)[2][6] These properties make isobaric ropivacaine a potentially better choice for spinal anesthesia in lower abdominal surgeries and other procedures where rapid recovery is desired[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isobaric ropivacaine.